TOBAM’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$471K Buy
+894
New +$501K 0.11% 146
2024
Q3
Sell
-146
Closed -$71K 334
2024
Q2
$71K Sell
146
-51
-26% -$25.6K 0.01% 287
2024
Q1
$106K Sell
197
-126
-39% -$68.9K 0.01% 291
2023
Q4
$179K Sell
323
-204
-39% -$95.8K 0.02% 235
2023
Q3
$230K Buy
527
+147
+39% +$73.3K 0.02% 204
2023
Q2
$191K Sell
380
-71
-16% -$34K 0.01% 246
2023
Q1
$226K Buy
451
+1
+0.2% +$479 0.01% 202
2022
Q4
$184K Buy
450
+82
+22% +$31.8K 0.01% 205
2022
Q3
$120K Sell
368
-95
-21% -$34.9K 0.01% 256
2022
Q2
$162K Buy
463
+93
+25% +$37.9K 0.01% 260
2022
Q1
$202K Buy
370
+146
+65% +$76.8K 0.01% 232
2021
Q4
$147K Sell
224
-64
-22% -$40.2K 0.01% 215
2021
Q3
$179K Hold
288
0.01% 208
2021
Q2
$182K Hold
288
0.01% 205
2021
Q1
$141K Hold
288
0.01% 214
2020
Q4
$144K Hold
288
0.01% 210
2020
Q3
$113K Buy
+288
New +$106K 0.01% 212
2017
Q2
Sell
-8,547
Closed -$1.32M 139
2017
Q1
$1.32M Sell
8,547
-14,930
-64% -$2.06M 0.05% 113
2016
Q4
$2.75M Buy
23,477
+644
+3% +$73.5K 0.11% 94
2016
Q3
$2.57M Buy
+22,833
New +$2.41M 0.09% 93

Other funds holding IDXX

TOBAM's IDXX Position: Q2 2026 in Review

TOBAM opened a new position in Idexx Laboratories (IDXX) in Q2 2026: 894 shares worth $471K. The stake represents 0.11% of the portfolio and ranks #146 among its holdings. This is a return to the name: TOBAM previously reported a position in IDXX as recently as Q2 2024.

TOBAM first reported a position in IDXX in Q3 2016 and has held it in 20 quarters since. The position peaked at $2.75M in Q4 2016. 1,301 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • TOBAM held 894 shares of Idexx Laboratories worth $471K as of Q2 2026.
  • Idexx Laboratories was a new TOBAM position in Q2 2026.
  • Idexx Laboratories made up 0.11% of TOBAM's portfolio in Q2 2026, its #146 holding.
  • TOBAM first reported a position in Idexx Laboratories in Q3 2016 and has held it in 20 quarters since.
  • TOBAM's Idexx Laboratories position peaked at $2.75M in Q4 2016.
  • 1,301 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on TOBAM's 13F filing for Q2 2026, filed 31 Jul 2026.